RRx-001 in Lung Cancer, Ovarian Cancer and Neuroendocrine Tumors Prior to Re-administration of Platinum Based Doublet Regimens (QUADRUPLE THREAT)

Clinical trial NCT02489903 · COMPLETED

Trial details

NCT number: NCT02489903
Sponsor: EpicentRx, Inc.
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Small Cell Carcinoma Carcinoma, Non-Small-Cell Lung Neuroendocrine Tumors Ovarian Epithelial Cancer

Start date: 2015-06-01
Primary completion: 2021-12-06
Enrollment: 139

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.